Biotech Archives - Page 100 of 795

2 minute read

Lantheus Announces Collaboration To Provide Novel Tau Imaging Agent For Large Consortium Clinical Trial Sponsored By The National Institute On Aging

February 13, 9:42 AM

Lantheus to supply MK-6240, an investigational F18-labeled PET imaging agent that targets tau tangles BEDFORD, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading

LNTH

3 minute read

Premier, Inc.’s PINC AI Applied Sciences And Datavant Collaborate To Enable Next-Generation Clinical Trials

By Benzinga Newsdesk

February 13, 9:36 AM

Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-preserving record linkage technology to help solve key clinical trial challenges.Aims to

PINC

2 minute read

Veradigm And American College Of Cardiology Launch Influenza Vaccination Education Initiative To Improve Cardiovascular Health

By Benzinga Newsdesk

February 13, 9:14 AM

Veradigm Inc. (NASDAQ:MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving

MDRX

2 minute read

Tonix Pharmaceuticals Announces Engagement Of Rho As CRO To Support Submission Of New Drug Application To The FDA For Approval Of Tonmya For The Management Of Fibromyalgia

By Benzinga Newsdesk

February 13, 9:12 AM

Tonmya™ is a potential new first-line therapy, non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials New Drug Application (NDA)

TNXP

3 minute read

Smith+Nephew Announces Commercial Launch Of Its AETOS Shoulder System For Anatomic And Reverse Shoulder Replacement At AAOS 2024 Annual Meeting

By Benzinga Newsdesk

February 13, 9:10 AM

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN◊ 3D

SNN

2 minute read

Phathom Pharmaceuticals Announces VOQUEZNA Tablets For Erosive GERD And Associated Heartburn Added To Express Scripts National Formularies For Commercial Patients

By Benzinga Newsdesk

February 13, 9:07 AM

One of the largest pharmacy benefit management (PBM) companies in the United States has added VOQUEZNA (vonoprazan) tablets to its national formularies for commercial plans, effective immediately FLORHAM PARK, N.J.,

PHAT

3 minute read

Pasithea Therapeutics Announces Opening Of Enrollment In The U.S. For Its Phase 1 Trial Of PAS-004

By Benzinga Newsdesk

February 13, 8:59 AM

-- Activation of four U.S. sites for Phase 1 clinical trial of PAS-004 to evaluate safety, dose, key biomarker data and preliminary efficacy ---- Plans to open three additional sites in Eastern Europe in the coming

KTTA

2 minute read

Revvity Signals Software Unveils Signals Clinical Solution To Accelerate Critical Clinical Trial Insights And Data-Driven Decisions

By Happy Mohamed

February 12, 5:09 PM

- Centralized data science platform streamlines clinical study data management for swift, insight-driven clinical decisions and therapeutic advancements - Seamless integration with Spotfire® for

RVTY

2 minute read

Gene Therapy Player REGENXBIO’s RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst

By Vandana Singh

February 12, 3:35 PM

Insights from Wedbush analysts about the clinical effectiveness of REGENXBIO's RGX-202, market potential, and challenges posed by competitors like Sarepta Therapeutics and Pfizer.

DNLI

1 minute read

This Analyst Slightly Lowers AstraZeneca Forecast Amid Earnings Concerns, Although Still Bullish on Future Growth Potential

By Vandana Singh

February 12, 3:18 PM

AstraZeneca reported Q4 2023 sales of $12.02B, up 7%, below consensus. Excluding COVID-19 drugs, revenue increased by 16%. Core EPS was $1.45, missing consensus. BMO Capital maintains Outperform rating.

AZN